X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-12 | ZNTL | Epperly Melissa B, | CFO | S - Sale | $11.44 | -2,573 | 451,449 | -1% | -$29,435 | ||||||
2024-02-12 | ZNTL | Gallagher Cam | Pres | S - Sale | $11.44 | -1,173 | 643,277 | 0% | -$13,419 | ||||||
| D | 2024-02-02 | ZNTL | Lackner Mark | Chief Scientific Officer | S - Sale+OE | $11.54 | -1,585 | 195,728 | -1% | -$18,291 | |||||
| D | 2024-02-02 | ZNTL | Paul Andrea | GC | S - Sale+OE | $11.54 | -3,310 | 149,973 | -2% | -$38,197 | |||||
| D | 2024-02-02 | ZNTL | Gallagher Cam | Pres | S - Sale+OE | $11.54 | -11,552 | 644,450 | -2% | -$133,310 | |||||
| D | 2024-02-02 | ZNTL | Epperly Melissa B, | CFO | S - Sale+OE | $11.54 | -8,669 | 454,022 | -2% | -$100,040 | |||||
2023-11-10 | ZNTL | Johnson David Michael | Dir | P - Purchase | $9.88 | +17,000 | 144,389 | +13% | +$167,943 | ||||||
2023-11-13 | ZNTL | Blackwell Kimberly | CEO | P - Purchase | $10.29 | +5,000 | 254,800 | +2% | +$51,448 | ||||||
2023-10-04 | ZNTL | Brownstein Carrie | Chief Medical Officer | S - Sale | $19.50 | -10,628 | 105,685 | -9% | -$207,298 | ||||||
2023-10-04 | ZNTL | Bunker Kevin D. | Chief Scientific Officer | S - Sale | $19.50 | -6,068 | 874,439 | -1% | -$118,355 | ||||||
2023-10-04 | ZNTL | Epperly Melissa B, | CFO | S - Sale | $19.50 | -5,482 | 387,691 | -1% | -$106,926 | ||||||
2023-09-11 | ZNTL | Skvarka Jan | Dir | S - Sale | $25.05 | -5,000 | 47,970 | -9% | -$125,238 | ||||||
2023-06-20 | ZNTL | Matrix Capital Management Company, LP | 10% | P - Purchase | $22.66 | +4,760,000 | 13,959,973 | +52% | +$107,861,600 | ||||||
2023-05-31 | ZNTL | Gallagher Cam | Pres | S - Sale | $26.27 | -27,768 | 463,502 | -6% | -$729,506 | ||||||
2023-05-26 | ZNTL | Bunker Kevin D. | Chief Scientific Officer | S - Sale | $30.02 | -80,000 | 880,507 | -8% | -$2,401,248 | ||||||
| M | 2023-02-13 | ZNTL | Epperly Melissa B, | CFO | S - Sale | $20.13 | -7,851 | 392,048 | -2% | -$158,005 | |||||
| M | 2023-02-13 | ZNTL | Gallagher Cam | Pres | S - Sale | $20.09 | -11,833 | 491,270 | -2% | -$237,760 | |||||
| M | 2023-02-13 | ZNTL | Bunker Kevin D. | Chief Scientific Officer | S - Sale | $20.14 | -10,307 | 960,507 | -1% | -$207,629 | |||||
2023-02-06 | ZNTL | Gallagher Cam | Pres | S - Sale | $22.27 | -10,000 | 503,103 | -2% | -$222,678 | ||||||
2023-01-17 | ZNTL | Gallagher Cam | Pres | S - Sale | $24.15 | -10,000 | 352,011 | -3% | -$241,515 | ||||||
2023-01-05 | ZNTL | Gallagher Cam | Pres | S - Sale | $21.02 | -10,000 | 362,011 | -3% | -$210,228 | ||||||
2022-11-15 | ZNTL | Gallagher Cam | Pres | S - Sale | $22.77 | -12,500 | 372,011 | -3% | -$284,683 | ||||||
| M | 2022-11-07 | ZNTL | Gallagher Cam | Pres | S - Sale | $23.62 | -24,874 | 384,511 | -6% | -$587,403 | |||||
2022-10-17 | ZNTL | Gallagher Cam | Pres | S - Sale | $23.51 | -12,500 | 409,385 | -3% | -$293,879 | ||||||
| M | 2022-10-05 | ZNTL | Gallagher Cam | Pres | S - Sale | $22.45 | -22,500 | 421,885 | -5% | -$505,186 | |||||
| M | 2022-09-15 | ZNTL | Gallagher Cam | Pres | S - Sale | $24.90 | -22,500 | 444,385 | -5% | -$560,254 | |||||
2022-08-10 | ZNTL | Bunker Kevin D. | COO | S - Sale | $30.00 | -5,000 | 859,460 | -1% | -$150,000 | ||||||
2022-07-20 | ZNTL | Bunker Kevin D. | COO | S - Sale | $30.00 | -5,000 | 864,460 | -1% | -$150,000 | ||||||
| M | 2022-07-13 | ZNTL | Bunker Kevin D. | COO | S - Sale | $30.01 | -5,000 | 869,460 | -1% | -$150,062 | |||||
2022-07-05 | ZNTL | Bunker Kevin D. | COO | S - Sale | $30.07 | -25,000 | 874,460 | -3% | -$751,653 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |